233 related articles for article (PubMed ID: 30874541)
1. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma.
Ma J; Peng J; Mo R; Ma S; Wang J; Zang L; Li W; Fan J
Biochem Biophys Res Commun; 2015 Aug; 464(1):147-53. PubMed ID: 26102039
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.
Zhang Y; Lu Y; Xu Y; Le Z; Liu Y; Tu W; Liu Y
Life Sci; 2023 May; 321():121594. PubMed ID: 36934971
[TBL] [Abstract][Full Text] [Related]
6. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
7. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
[TBL] [Abstract][Full Text] [Related]
8. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
[TBL] [Abstract][Full Text] [Related]
9. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
Wang G; Zhuang Z; Shen S; Yang F; Jiang Z; Liu Z; Wang T; Hua L
Hum Cell; 2022 May; 35(3):896-908. PubMed ID: 35174471
[TBL] [Abstract][Full Text] [Related]
11. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
12. CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.
Taniguchi H; Ito S; Ueda T; Morioka Y; Kayukawa N; Ueno A; Nakagawa H; Fujihara A; Ushijima S; Kanazawa M; Hongo F; Ukimura O
Biochem Biophys Res Commun; 2017 Apr; 485(2):267-271. PubMed ID: 28235487
[TBL] [Abstract][Full Text] [Related]
13. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
15. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
Yang G; Gong Y; Wang Q; Wang L; Zhang X
Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
[TBL] [Abstract][Full Text] [Related]
16. The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis.
Wang Y; Peng M; Zhong Y; Xiong W; Zhu L; Jin X
Oncogene; 2023 Mar; 42(13):952-966. PubMed ID: 36732658
[TBL] [Abstract][Full Text] [Related]
17. RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).
Liu ML; Zang F; Zhang SJ
Biomed Pharmacother; 2019 Oct; 118():109250. PubMed ID: 31545242
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
19. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.
Fukawa T; Ono M; Matsuo T; Uehara H; Miki T; Nakamura Y; Kanayama HO; Katagiri T
Cancer Res; 2012 Nov; 72(22):5867-77. PubMed ID: 23019224
[TBL] [Abstract][Full Text] [Related]
20. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
Macher-Goeppinger S; Keith M; Tagscherer KE; Singer S; Winkler J; Hofmann TG; Pahernik S; Duensing S; Hohenfellner M; Kopitz J; Schirmacher P; Roth W
J Pathol; 2015 Dec; 237(4):460-71. PubMed ID: 26178300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]